Across TCGA pan-cancer cohorts, SNRPCP18 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SNRPCP18’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SNRPCP18 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNRPCP18 is over-expressed in tumor.
KIRC and LUAD are the cancer types where SNRPCP18 tumor–normal differential expression is most reproducible.